Find out here the who's who and the what's what

Wednesday, November 14, 2007

Nutrition

Children and adolescents

As they grow and develop, the nutritional needs of children and adolescents differ from those of adults. According the National Health and Medical Research Council (NHMRC), the following guidelines apply to those aged from birth to eighteen years:
· Encourage and support breast feeding
· Children and adolescents need sufficient nutritious foods to grow and develop normally. Growth should be checked regularly for young children, and physical activity is important for all children and adolescents
· Enjoy a wide variety of nutritious foods
· Children and adolescents should be encouraged to eat plenty of vegetables, legumes, fruits and cereals (including breads, rice, pasta and noodles – preferably wholegrain)
· Include lean meat, fish, poultry and/or alternatives
· Include milks, yoghurts, cheese and/or alternatives
· Reduced-fat milks are not suitable for young children under two years because of their high energy needs, but reduced-fat varieties should be encouraged for older children and adolescents
· Choose water as a drink
· Alcohol is not recommended for children
· Care should be taken to limit saturated fat and moderate total fat intake
· Low-fat diets are not suitable for infants
· Choose foods low in salt
· Consume only moderate amounts of sugars and foods containing added sugars
· Care for your child’s food: prepare and store it safely

Mannatech has been a pioneer and unsurpassed world leader in “glyconutrient (sweet nutrient) supplements” since 1994. Glyconutrient supplements are now recognized and defined in Harper’s Illustrated Biochemistry, a premier scientific textbook used in universities and medical schools worldwide. These products, which include sources of the same sugars found in glycoproteins, appear to have numerous structure/function mechanisms within the human body. Mannatech’s proprietary glyconutrient technology is currently covered by over 20 patents issued worldwide with more patents pending.

No comments: